CBS 2019
CBSMD教育中心
English

动脉粥样硬化性心血管疾病

科研文章

荐读文献

2019 Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD ESC Clinical Practice Guidelines Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel Primary Prevention Trial Designs Using Coronary Imaging: A National Heart, Lung, and Blood Institute Workshop High-Risk Coronary Plaque Regression After Intensive Lifestyle Intervention in Nonbstructive Coronary Disease: A Randomized Study The sinus venosus contributes to coronary vasculature through VEGFC-stimulated angiogenesis Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular DiseaseA Prespecified Analysis From the FOURIER Trial Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes

Guideline2018 Sep 25;138(13):e415-e418.

JOURNAL:Circulation. Article Link

2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

Al-Khatib SM, Stevenson WG, Ackerman MJ et al. Keywords: AHA Scientific Statements; CT imaging; ECG; MR imaging; acute coronary syndrome; ambulatory ECG monitoring; antiarrhythmic drug therapy; arrhythmogenic cardiomyopathy; athletes; cardiac electrophysiology; cardiac resynchronization therapy; cardiomyopathy; catheter ablation; congenital heart disease; echocardiography; electrophysiological testing; genetic arrhythmias; guidelines; heart failure; imaging; implantable and external cardioverter devices; implantable cardioverter-defibrillator; medication-induced arrhythmias; myocardial infarction; premature ventricular beats; resuscitation; sarcoidosis; specific pathology (eg, congenital heart disease, myocarditis, renal failure); stable coronary artery disease; sudden cardiac arrest; sudden cardiac death; torsades de pointes; ventricular fibrillation; ventricular tachycardia

FULL TEXT PDF